Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2013 10:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Present at the 2013 Aegis Capital Healthcare Conference

SEATTLE, WA--(Marketwired - Sep 24, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, Chief Financial Officer & General Counsel,...
September 23, 2013 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Conduct Free Webinar: How to Invest Ahead of Breast Cancer Awareness Month

SEATTLE, WA--(Marketwired - Sep 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, today announced that Dr. Steven C. Quay, Chairman, President & CEO, will...
July 13, 2011 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Acquires Rights to Patents Covering a Novel Screening Test for Breast Cancer From the Dr. Susan Love Research Foundation

SEATTLE, WA--(Marketwire - Jul 13, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
June 27, 2011 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Completes $6.6 Million Over-Subscribed Private Placement

SEATTLE, WA--(Marketwire - Jun 27, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
May 24, 2011 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Announces Licensing of Its New National Reference Laboratory for Breast Health

SEATTLE, WA--(Marketwire - May 24, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
May 03, 2011 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics, Inc. and HLB, LLC Announce Partnership to Manufacture Atossa's Patented, FDA-Cleared MASCT System for Breast Cancer Risk Assessment

SEATTLE, WA and CHICAGO, IL--(Marketwire - May 3, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular...
April 14, 2011 11:28 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Appoints Tim Hunkapiller, Ph.D., to Its Scientific Advisory Board

SEATTLE, WA--(Marketwire - Apr 14, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
March 14, 2011 08:00 ET | Source: Atossa Genetics, Inc.

Steven C. Quay, M.D., Ph.D., of Atossa Genetics Elected as a Fellow of the College of American Pathologists

SEATTLE, WA--(Marketwire - March 14, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
March 04, 2011 08:30 ET | Source: Atossa Genetics, Inc.

Seattle Business Magazine Recognizes Steven C. Quay, M.D., Ph.D., of Atossa Genetics, Inc., as One of the Pacific Northwest's Top Leaders in Health Care

SEATTLE, WA--(Marketwire - March 4, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
October 01, 2010 09:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics, Inc. Announces Filing of S-1 Registration Statement

SEATTLE, WA--(Marketwire - October 1, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk...

Next Page keyboard_arrow_right